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Summary
Objective: To investigate the presence of mesenchymal precursor cells (MPCs) in synovial surface projections of patients with osteoarthritis
(OA), to characterize their phenotype and to show their localization.
Methods: Progenitor cells in synovial surface projections were identiﬁed by immunohistochemistry, morphometric analysis and confocal laser
scanning microscopy using the following phenotypic markers: STRO-1, CD34, and alpha smooth muscle actin (a-SMA).
Results: In the synovial tissue of all 21 patients with OA MPCs were detected. Immunohistochemistry and subsequent morphometric analysis
showed that approximately twice as many STRO-1þ cells/mm2 were observed in synovial tissue of patients with OA as compared to healthy
organ donors and that number of STRO-1þ cells/mm2 correlated with total cell number/mm2. Interestingly, in the synovial tissue of patients
with OA, twice as many STRO-1þ cells/mm2 were found in synovial surface projections as compared to the sublining area without villi. Using
confocal laser scanning microscopy two populations of STRO-1þ MPCs could be detected in synovial surface projections. Single STRO-1þ
cells that co-expressed a-SMA resemble a population of pericyte precursors required to stabilize the immature vasculature. The second
STRO-1þ cell population that was found lacked a-SMA but co-expressed CD34 on their surface with low intensity.
Conclusion: Here we can show that in the synovial tissue of patients with OA twice as many STRO-1þ MPCs can be found in synovial surface
projections as compared to the sublining area. These cells are preferentially located at the basis and in the protruding end of the synovial
surface projection.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is a degenerative disease which results
from aging and abnormal biomechanical stress loading on
cartilage and subchondral bone. The synovial membrane
can benormal in appearance, showing no intimal hyperplasia
or cellular inﬁltrate, though there can be ﬁbrosis, increased
vasculature, and incorporation of fragments of cartilage and
bone from the joint surface. A number of caseswith OA, how-
ever, present features of a noninfectious inﬂammatory condi-
tion with chronic synovitis including intimal cell hyperplasia,
inﬁltration of lymphocytes, plasma cells and cells from the
monocyte/macrophage lineage and synovial surface projec-
tions. During degenerative and/or noninfectious inﬂamma-
tory processes in OA, the damaged articular cartilage and
bone can be replaced by newly differentiated cells derived
from progenitor cells or by self-repair induced by fully differ-
entiated resident cells of the joint1,2. Mesenchymal precursor
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2006.9cells (MPCs) are under intense investigation for their high re-
generative potential and their ability of self-renewal and dif-
ferentiation into various connective tissue lineages, i.e.
chondroblasts, osteoblasts, adipocytes and smooth muscle
cells2e5. Mesenchymal cells co-expressing bone morphoge-
netic protein receptor (BMPR) IA and BMPR II but not CD34
could be successfully generated in primary cultures from
cells isolated from joint effusions of patients with rheumatoid
arthritis (RA) and other forms of inﬂammatory arthritis6. Mes-
enchymal cells were also found in the intimal lining layer and
in the subintima of the synovial tissue, scattered in areas with
small blood vessels and lymphoid aggregates6e8. Recently
we have shown that MPCs within the synovial sublining
area of patients with RA and OA express STRO-1 on their
cell surface, and that they reside in close proximity to
CD133þ and CD34þ progenitor cells9. These cells form cell
clusters, where STRO-1þ MPCs were found on the outside
of the cluster together with CD133þ precursor cells surround-
ing CD34þ progenitor cells in the center. MPCs isolated from
synovial membranes, obtained from adult human joints,
could be expanded in vitro and maintained their multilineage
differentiation potential8,10. MPCs from joint effusions and
from bone marrow aspirates showed a similar phenotype
and comparable capacity to form colony forming units-ﬁbro-
blasts, and MPCs in the synovial ﬂuid were more numerous
in patients with OA than in healthy individuals11.38
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ticular microenvironments known as niches, have a lifelong
capability to replace impaired or lost cell populations and
counteract degeneration2. On the other hand, MPCs might
also be responsible for extensive synovial connective tis-
sue proliferation and formation of villous projections as
seen in OA. Here we investigate whether MPCs can be
found in synovial surface projections of patients with OA
and try to characterize their phenotype. It was speculated
that synovial villi do not form simply by outgrowth, but
rather by tissue splitting, surface bridging and subintimal
cavitation12.
Material and methods
PATIENTS
Synovial tissue of 21 OA patients was obtained at the
time of surgery for knee and hip arthroplasty after informed
consent was obtained. Patients with OA fulﬁlled the respec-
tive classiﬁcation criteria13. Of the 21 OA patients, 14 had
knee surgery with a mean Knee Society Score of 42 points
(SD 18, range 9e64)/46 points (SD 19, range 10e80), and
seven had hip surgery with a mean Harris Hip Score of 47
points (SD 4, range 42e55). Synovial tissue of 11 joints
from three organ donors was obtained in accordance with
the European Society for Organ Transplantation and with
the Austrian Hospital Act (KAG 1982, x62 a, b, c).
IMMUNOHISTOCHEMISTRY AND MORPHOMETRIC ANALYSIS
Sections (5 mm) of snap-frozen synovial membrane sam-
ples from patients with OA and organ donors were prepared
and immunohistochemistry performed as previously re-
ported9. Acetone-ﬁxed sections were incubated overnight
at 4(C with the following mouse monoclonal antibodies
diluted in Tris buffered saline (TBS)/1% bovine serum albu-
min (BSA): STRO-1 (1.8 mg/ml; Developmental Studies
Hybridoma Bank, IA), CD34 (0.5 mg/ml; Immunotech,
Marseille, France), VEGFR-2 (2.5 mg/ml; Santa Cruz Bio-
technology, Santa Cruz, CA), CXCR4/Fusin (2.5 mg/ml;
PharMingen, San Diego, CA) and anti-muscle speciﬁc actin
a and g [alpha smooth muscle actin (a-SMA)] (0.5 mg/ml;
Sigma, St. Louis, MO). The reactivity of primary antibodies
was revealedusingbiotinylated sheepF(ab0)2 anti-mouse im-
munoglobulin (Ig) (1:100; An der Grub, Kaumberg, Austria)
diluted in 500 mg/ml normal human Ig (Intraglobin F, Biotest,
Dreieich, Germany) followed by streptavidinehorseradish
peroxidase (HRP) complex (1:100; ExtravidineHRP,
Sigma). Endogenous peroxidase was blocked during the in-
cubation with secondary antibody by adding D-glucose and
glucose-oxidase type VII. For the detection of STRO-1 and
CXCR4 mAb binding, a super-sensitive detection system con-
sisting of biotinylated goat anti-mouse Ig and streptavidine
HRP (Biocare Medical, Carlsbad, CA) was used. Omission
of primary antibody and isotype controls was included in the
protocol. The sections were exposed to 3-amino-9-ethylcar-
bazole (AEC; Sigma) and counterstained with Mayer’s
Hemalum. Morphometric analysis was performed by count-
ing the number of STRO-1þ cells as well as the total number
of cells in 10 ﬁelds of 1 mm2 selected at random as described
earlier9. Student’s t test was used to evaluate differences in
the number of STRO-1þ cells/mm2 in the synovial surface
projection compared to the number of STRO-1þ cells/mm2
in the sublining area without villi. Differences were consid-
ered statistically signiﬁcant when P< 0.05.THREE-COLOR LASER SCANNING CONFOCAL MICROSCOPY
For immunoﬂuorescence studies, acetone-ﬁxed synovial
tissue sections (5 mm) were prepared, incubated overnight
at 4(C with STRO-1 (1.8 mg/ml) diluted in TBS/1%BSA.
Staining of the mouse IgM mAb STRO-1 was revealed us-
ing a biotin-conjugated goat anti-mouse IgM (2.5 mg/ml;
Sigma) followed by a streptavidineCy5 complex (2 mg/ml;
Jackson ImmunoResearch, West Grove, PA). After block-
ing tissue sections with normal mouse serum (1:5), they
were incubated with anti-a-SMA (1 mg/ml; Neo-Markers
Inc., Fremont, CA) labeled with Alexa-Fluor 594 (Molecular
Probes Inc., Eugene, OR) and with CD34 FITC (5 mg/ml;
Becton Dickinson, San Jose, CA) overnight at 4(C. Serial
dilutions of each primary and secondary antibody were
tested to minimize nonspeciﬁc binding, assure separation
of the ﬂuorescent signals, and optimize ﬂuorophore concen-
tration to preclude self-quenching. Sections were analyzed
with a laser scanning confocal microscopy (LSM 510; Zeiss,
Oberkochen, Germany) with multiphoton laser (argon-laser:
488 nm for FITC, HeNe 1: 585 nm for AF594, and HeNe 2:
633 nm for Cy5) and a 63 Zeiss Plan-Apochromat DIC oil
immersion objective with numerical aperture 1.40.
Results
Of the 21 patients with OA investigated, 13 patients
showed synovial surface projections. Eight of them had
massive lymphocyte inﬁltration, while in ﬁve modest or no
signs of lymphocyte ingress were found. Two patients
showed lymphocyte inﬁltration, without synovial surface
projections, and in the synovial tissue of the remaining six
patients no synovial villi and hardly any leukocyte inﬁltration
were found. Morphometric analysis showed that, although
not statistically signiﬁcant, approximately two times more
STRO-1þ cells/mm2 were observed within the synovial
sublining area of patients with OA as compared to healthy
organ donors (Table I). In both groups the number of
STRO-1þ cells/mm2 correlated positively with total cell
number/mm2. Interestingly, twice as many STRO-1þ
cells/mm2 were found in synovial surface projections as
compared to the sublining area without villi (Table I, the
Table I
Morphometric analysis of total cells and STRO-1þ cells/mm2 in the
sublining area of the synovial tissue and in synovial surface projec-
tions of patients with OA
Total
cells/mm2
STRO-1/mm2
in the
sublining area
STRO-1/mm2
in synovial
surface
projection
Patients with
synovial surface
projections (n¼ 13)
304 120 5.4 3.3* 12.1 4.7*
Patients without
synovial surface
projections (n¼ 8)
208 81 4.8 4 e
Healthy
controls (n¼ 11)
128 13 2.4 1.3 e
Results are given as meanSD, and the Student’s t test was
used to evaluate differences in the number of STRO-1þ cells/mm2 in
the sublining area compared to the number of STRO-1þ cells/mm2
in synovial surface projections, obtained by morphometric analysis.
Differences were considered statistically signiﬁcant when P< 0.05,
indicated by an asterisk.
940 A. Giurea et al.: Mesenchymal precursor cells in synovial villiFig. 1. Expression of STRO-1 and CD34 on precursor cells in serial sections of synovial tissue obtained from two representative patients with
OA. Serial sections of synovial membranes from patient 1 (A,C,E) and patient 2 (B,D,F) were stained with the mesenchymal precursor cell
marker STRO-1 (A,B), with the endothelial and stem cell marker CD34 (C,D) and with an isotype control (E,F), and were counterstained
with Mayer’s Hemalum. The two images were selected to show a synovial surface projection longitudinal (A,C,E) and transversal (B,D,F) (orig-
inal magniﬁcation 150).statistical difference is indicated with an asterisk). Serial
longitudinal cross sections of a synovial surface projection
of one representative patient with OA are shown in
Fig. 1(A,C,E), where STRO-1þ cells are found in small
cell clusters [Fig. 1(A)] surrounding CD34þ precursor cells
[Fig. 1(C)]. Figure 1(B,D,F) gives the transversal imageof the basis of a synovial surface projection of another
representative patient with OA. Here, STRO-1þ cells are
scattered within the interior in groups of 3e10 cells sur-
rounding CD34þ precursors [Fig. 1(B,D)]. Immunohisto-
chemistry gives perfect morphologic images, but this
technique is not precise enough to answer the question ofFig. 2. Three-color laser scans showing the expression of STRO-1, CD34 and a-SMA on precursor cells located within a synovial surface
projection of a patient with OA. Acetone-ﬁxed synovial tissue sections (5 mm) were incubated with mouse IgM mAb STRO-1 and staining
was revealed using a biotin-conjugated goat anti-mouse IgM followed by a streptavidineCy5 complex. After blocking tissue sections were in-
cubated with anti-a-SMA labeled with Alexa-Fluor 594 and with CD34 FITC overnight at 4(C. Sections were analyzed with a confocal laser
scanning microscope (LSM 510, Zeiss, Oberkochen, Germany) and a differential interference contrast oil immersion objective. Single scans
showing precursor cells staining positive for CD34 green (B,F,J), STRO-1 blue (C,G,K) and a-SMA red (D,H,L), and overlays of all three scans
are shown in A, E, and I (the magniﬁcation of AeD is 630 and of EeL 850).
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942 A. Giurea et al.: Mesenchymal precursor cells in synovial villiwhether these STRO-1þ cells also co-express the pericyte
marker a-SMA, and the endothelial and stem cell marker
CD34. Confocal laser scanning microscopy is the perfect
tool to demonstrate co-localization of STRO-1, CD34 and
a-SMA on the cellular level. Three-color images with
CD34þ cells in green, a-SMAþ cells in red and STRO-1þ
cells in blue show a synovial surface projection of a patient
with OA in longitudinal orientation [Fig. 2(A,B,C,D)], a sub-
lining area of synovial membrane obtained from a patient
with OA [Fig. 2(E,F,G,H)], and a sublining area of a healthy
individual [Fig. 2(I,J,K,L)]. Interestingly, the majority of
STRO-1þ cells [Fig. 2(A,D)] within the synovial surface
projections did not express a-SMA [Fig. 2(A,C)], and only
a minor STRO-1þ cell population existed that co-expressed
a-SMA on the surface, representing the population of peri-
cyte precursors required to stabilize the immature vascula-
ture. Single STRO-1þ precursors co-expressed CD34 on
their surface, but with low intensity [Fig. 2(A)]. Certain
CD34þ precursors that co-expressed STRO-1 very dimly
were also detected, but they represent a rare population
[Fig. 2(A) and data not shown]. In the sublining area of
the synovial membrane of both patients with OA and
healthy individuals, the majority of STRO-1þ cells co-ex-
pressed a-SMA and were located in areas of new vessel
formation [Fig. 2(E,G,I,K)]. Here single STRO-1þ precursors
also co-expressed CD34 on their surface with low intensity.
Discussion
The damaged articular cartilage and subchondral bone
can be replaced by newly differentiated cells derived from
a limited number of readily available resident multipotent
MPCs or by fully differentiated cells of the joint1e4,14,15.
MPCs resident in small niches in the peripheral tissue, are
recruited to differentiate into locally required mature cell
types, and are replaced by circulating MPCs which are in
a ‘steady state’ of equilibrium with the resident MPCs in
the niches16. In the joint of patients with OA MPCs could
be found in the synovial tissue, in cartilage and bone and
in joint effusions6e8,11,15. Within the synovial membrane
STRO-1þ MPCs were found in the sublining area in close
proximity to CD34þ and CD133þ progenitor cells, that are in-
volved in the de novo form of a primitive vascular network9.
These cells form cell clusters with CD34þ progenitor cells lo-
cated at the inside surrounded by CD133þ progenitor cells
and STRO-1þMPCs on the outside. STRO-1þ a-SMAþ cells
in these clusters show phenotypic features of immature peri-
cytes and/or pericyte precursors and can be recruited from
neighboring resident MPCs or migrate to the joint via circu-
lation. Pericytes are needed to coat the newly formed mi-
cro-vasculature and stabilize by preventing vessel
pruning17. In addition to the sublining area of the synovial tis-
sue, STRO-1þ MPCs can also be found in synovial surface
projections. Synovial villi were found in 13 of the 21 patients
with OA at the time of surgery for arthroplasty. Morphometric
analysis revealed that the number of STRO-1þ MPCs/mm2
were two times higher in synovial surface projections than
in the sublining area of synovial membranes without villi.
Within these synovial surface projections MPCs are prefer-
entially located at the basis and at the protruding end. Inter-
estingly, the majority of STRO-1þ MPCs did not express a-
SMA on their surface and it seems likely that they represent
a different population of MPCs as compared to MPCs in the
sublining area. Confocal microscopy showed a minor
STRO-1þ/a-SMA MPC population expressing CD34 on
their surface, but with low intensity.The presence of MPCs in the synovial tissue of patients
with OA raises the question of whether these cells appear
in the joint as a result of inﬂammatory processes or whether
they are already present before the onset of the disease.
A murine collagen-induced arthritis model showed that
BMPRþ mesenchymal cells are among the earliest cells
to arrive at the pre-arthritic joint and their presence in the
chronic phase of arthritis is regulated by Tumor Necrosis
Factor (TNF)14. Further, synovial tissue of healthy organ do-
nors contains MPCs (Table I) and in every peripheral tissue
MPCs are found at various quantities with the bone marrow
serving as a reservoir1,4,16. Both homeostasis and canals
between bone marrow and synovium allow migration of
bone marrow stem cells into the synovium of inﬂamed
joints18. The mechanism of opening up bone canals is at
least partly osteoclast-mediated, as activated osteoclasts
were found in close proximity to the enlarged canals18.
In conclusion, we can say that in patients with OA twice
as many STRO-1þ MPCs were found in synovial surface
projections preferentially at the basis and at the protruding
end, as compared to the synovial sublining area without villi.
In addition, the number of STRO-1þ MPCs correlated with
lymphocyte inﬁltration. This is an interesting ﬁnding since
tissue repair activity is assumed to be intense in the syno-
vial tissue of patients with inﬂamed joints. Differentiated
cells of the mesenchymal lineage have a particular capabil-
ity, they can de-differentiate and then shift to another mes-
enchymal phenotype, which highlights the reversible nature
of differentiation of mesenchymal cells3,19. It seems likely
that, in OA, MPCs are, at least in part, responsible for exten-
sive synovial connective tissue proliferation and formation
of villous projections.
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